Radiotherapy and Renal Cell Carcinoma: A Continuing Saga

被引：10
作者：
Spyropoulou, Despoina [1 ]
Tsiganos, Panagiotis [2 ]
Dimitrakopoulos, Foteinos-Ioannis [3 ,4 ]
Tolia, Maria [5 ]
Koutras, Angelos [3 ]
Velissaris, Dimitris [6 ,7 ]
Lagadinou, Maria [6 ]
Papathanasiou, Nikolaos [8 ]
Gkantaifi, Areti [9 ]
Kalofonos, Haralabos [3 ]
Kardamakis, Dimitrios [1 ]
机构：
[1] Univ Patras, Med Sch, Dept Radiat Oncol, Univ Campus, Patras 26504, Greece
[2] Univ Patras, Dept Med, Clin Radiol Lab, Patras, Greece
[3] Univ Hosp Patras, Dept Med, Div Oncol, Patras, Greece
[4] Univ Patras, Med Sch, Clin & Mol Oncol Lab, Patras, Greece
[5] Univ Crete, Med Sch, Univ Hosp Heraklion, Radiotherapy Dept, Iraklion, Greece
[6] Univ Hosp Patras, Emergency Dept, Patras, Greece
[7] Univ Hosp Patras, Internal Med Dept, Patras, Greece
[8] Univ Hosp Patras, Nucl Med & PET CT Dept, Patras, Greece
[9] Interbalkan Med Ctr, Radiotherapy Dept, Thessaloniki, Greece
来源：
IN VIVO | 2021年 / 35卷 / 03期
关键词：
Renal cell cancer; radiotherapy; radioresistance; radiosensitivity; oligometastatic disease; stereotactic body radiation therapy; review; EXTERNAL-BEAM RADIOTHERAPY; STEREOTACTIC BODY RADIOTHERAPY; LONG-TERM OUTCOMES; BRAIN METASTASES; POSTOPERATIVE RADIOTHERAPY; RADIATION-THERAPY; RANDOMIZED-TRIAL; PROGNOSTIC-FACTORS; SYSTEMIC THERAPY; STAGE-II;
D O I：
10.21873/invivo.12389
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Renal cell carcinoma (RCC) is one of the most aggressive malignancies of the genito-urinary tract, having a poor prognosis especially in patients with metastasis. Surgical resection remains the gold standard for localized renal cancer disease, with radiotherapy (RT) receiving much skepticism during the last decades. However, many studies have evaluated the role of RT, and although renal cancer is traditionally considered radio-resistant, technological advances in the RT field with regards to modern linear accelerators, as well as advanced RT techniques have resulted in breakthrough therapeutic outcomes. Additionally, the combination of RT with immune checkpoint inhibitors and targeted agents may maximize the clinical benefit. This review article focuses on the role of RT in the therapeutic management of renal cell carcinoma.
引用
收藏
页码：1365 / 1377
页数：13
相关论文
共 89 条
  • [31] Final results of a dose escalation protocol of stereotactic body radiotherapy for poor surgical candidates with localized renal cell carcinoma
    Grubb, William R.
    Ponsky, Lee
    Lo, Simon S.
    Kharouta, Michael
    Traughber, Bryan
    Sandstrom, Kate
    MacLennan, Gregory T.
    Shankar, Eswar
    Gupta, Sanjay
    Machtay, Mitchell
    Ellis, Rodney J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 155 : 138 - 143
  • [32] Intraoperative electron radiation therapy (IOERT) in patients with locally recurrent renal cell carcinoma
    Habl, Gregor
    Uhl, Matthias
    Hensley, Frank
    Pahernik, Sascha
    Debus, Juergen
    Roeder, Falk
    [J]. RADIATION ONCOLOGY, 2013, 8
  • [33] LONG-TERM OUTCOMES AFTER MAXIMAL SURGICAL RESECTION AND INTRAOPERATIVE ELECTRON RADIOTHERAPY FOR LOCOREGIONALLY RECURRENT OR LOCOREGIONALLY ADVANCED PRIMARY RENAL CELL CARCINOMA
    Hallemeier, Christopher L.
    Choo, Richard
    Davis, Brian J.
    Pisansky, Thomas M.
    Gunderson, Leonard L.
    Leibovich, Bradley C.
    Haddock, Michael G.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (05): : 1938 - 1943
  • [34] Hammers Hans J., 2020, JOURNAL OF CLINICAL ONCOLOGY, V38
  • [35] Randomized trial of short-versus long-course radiotherapy for palliation of painful bone metastases
    Hartsell, WF
    Scott, CB
    Bruner, DW
    Scarantino, CW
    Ivker, RA
    Roach, M
    Suh, JH
    Demas, WF
    Movsas, B
    Petersen, IA
    Konski, AA
    Cleeland, CS
    Janjan, NA
    DeSilvio, M
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (11): : 798 - 804
  • [36] Survival Outcomes After Adding Stereotactic Body Radiotherapy to Metastatic Renal Cell Carcinoma Patients Treated With Tyrosine Kinase Inhibitors
    He, Liru
    Liu, Yang
    Han, Hui
    Liu, Zhuowei
    Huang, Sijuan
    Cao, Wufei
    Liu, Boji
    Qin, Zike
    Guo, Shengjie
    Zhang, Zhiling
    Lin, Maosheng
    Jiang, Xiaobo
    Lin, Chengguang
    Li, Yonghong
    Yao, Kai
    Dong, Pei
    Zhou, Fangjian
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (01): : 58 - 63
  • [37] Heinzer H, 2000, UROLOGE A, V39, P356, DOI 10.1007/s001200050370
  • [38] OLIGOMETASTASES
    HELLMAN, S
    WEICHSELBAUM, RR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) : 8 - 10
  • [39] Hepgur M, 2013, BIOL-TARGETS THER, V7, P139, DOI 10.2147/BTT.S32958
  • [40] Gamma knife radiosurgery for renal cell carcinoma brain metastases
    Hernandez, L
    Zamorano, L
    Sloan, A
    Fontanesi, J
    Lo, S
    Levin, K
    Li, QH
    Diaz, F
    [J]. JOURNAL OF NEUROSURGERY, 2002, 97 : 489 - 493
123456789